Currax Announces Outstanding 2024 Financial and Operational Performance
Hand-out
Press Releases
Currax Pharmaceuticals LLC  
January 10, 2025

Currax Announces Outstanding 2024 Financial and Operational Performance

Worldwide demand for CONTRAVE® / MYSIMBA® drove revenue growth of over 50% for the second year running

avatar profile Olean Times Herald

Olean Times Herald


Local & Social